Eris Lifesciences: Ask Some Questions, Take the Deal
Eris Lifesciences Limited (0113824Z IN) is an India-focused pharmaceutical company that produces and markets branded generic drugs. The company...
669 Views
An Early Look at WuXi Biologics
WuXi Biologics, a CRO/contract manufacturer focused on biologics, has filed an Application Proof with the HKEX for a new listing.Ā The document...
991 Views
Regeneron: Our Second Core Large-Cap Biotechnology Position.
We present our investment thesis forĀ Regeneron Pharmaceuticals (REGN US), another large-capĀ biotechnology company. We think that investors/analysts...
497 Views
New Long Position: Gene Therapy for Parkinson's Disease and Upcoming Catalysts
Our next long position is Voyager Therapeutics Inc (VYGR US)Ā , a Cambridge, Massachusetts-based emerging biotechnology company that is developing...
633 Views
New Long Position: 'Red Bull' like Immune Boost Against Cancer
Immune Design Corp (IMDZ US) is an emerging immuno-oncology company (based in Seattle, Washington) that is using its proprietary technology in...
486 Views